# Molecular Partners AG (MOLN)

> Healthcare · CH · Reports in CHF

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MOLN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | Fr. 0 | Fr. -16.77M | Fr. -14.47M | Fr. 3.33M | Fr. 68.25M |
| 2025 | Fr. 0 | Fr. -73.94M | Fr. -57.19M | Fr. 3.64M | Fr. 80.33M |
| 2024 | Fr. 4.99M | Fr. -54.26M | Fr. -57.74M | Fr. 2.44M | Fr. 141.64M |
| 2023 | Fr. 7.11M | Fr. -63.17M | Fr. -59.30M | Fr. 3.65M | Fr. 176.43M |
| 2022 | Fr. 194.79M | Fr. 121.09M | Fr. 120.39M | Fr. 4.85M | Fr. 235.17M |
| 2021 | Fr. 9.86M | Fr. -67.41M | Fr. -97.50M | Fr. 6.04M | Fr. 107.29M |
| 2020 | Fr. 10.03M | Fr. -67.35M | Fr. -32.73M | Fr. 7.22M | Fr. 107.22M |
| 2019 | Fr. 21.69M | Fr. -38.62M | Fr. -2.36M | Fr. 2.55M | Fr. 54.14M |
| 2018 | Fr. 11.04M | Fr. -39.48M | Fr. -45.76M | Fr. 0 | Fr. 91.70M |
| 2017 | Fr. 21.48M | Fr. -27.29M | Fr. -21.15M | Fr. 0 | Fr. 116.73M |
| 2016 | Fr. 24.98M | Fr. -20.18M | Fr. 0 | Fr. 0 | Fr. 135.80M |
| 2015 | Fr. 31.57M | Fr. -219.3K | Fr. 0 | Fr. 0 | Fr. 151.79M |
| 2014 | Fr. 35.59M | Fr. -3.03M | Fr. 3.11M | Fr. 0 | Fr. 148.48M |
| 2013 | Fr. 34.51M | Fr. 7.60M | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.28 |
| Current Ratio | 9.42 |

## Other views

- [Metrics](https://sponda.capital/en/MOLN.md)
- [Charts](https://sponda.capital/en/MOLN/charts.md)
- [Compare](https://sponda.capital/en/MOLN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.